Joël Sainsous

Prognostic impact of high-intensity lipid-lowering therapy under-prescription after acute myocardial infarction in women

Orianne Weizman, Marie Hauguel‐Moreau, Victoria Tea, Franck Albert et autres

be, fr (code pays fourni par la source)

Five-year clinical outcomes using the bioresorbable vascular scaffold: Insights from the FRANCE ABSORB registry

Quentin Landolff, Thierry Lefèvre, Jean Fajadet, Joël Sainsous et autres

fr, nc, be (code pays fourni par la source)

Three‐year clinical outcomes with the ABSORB bioresorbable vascular scaffold in real life: Insights from the France ABSORB registry

Thibault Lhermusier, Didier Carrié, Guillaume Cayla, Jean Fajadet et autres

fr (code pays fourni par la source)

Percutaneous coronary interventions with the Absorb Bioresorbable vascular scaffold in real life: 1-year results from the FRANCE ABSORB registry

Guillaume Cayla, René Köning, Jean Fajadet, Joël Sainsous et autres

fr (code pays fourni par la source)

6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin

Romain Didier, Marie Claude Morice, Paul Barragan, Arif A.L. Noryani et autres

fr, ae, hu (code pays fourni par la source)

TCT-51 In hospital and one month outcomes of 983 patients implanted with bioresorbable vascular scaffolds for Acute Coronary Syndroms ; subgroup of the prospective, all comers, controlled, multicenter, FRANCE ABSORB Registry.

Joël Sainsous, Jean Fajadet, Didier Carrié, Simon Elhadad et autres

fr (code pays fourni par la source)

0505: Bioresorbable vascular scaffold: preliminary experience of 200 patients and follow up at 18 months of the first 100

Joël Sainsous, Jérôme Brunet, François Xavier Hager, Gilles Bayet et autres

0146 : Bioresorbable everolimus eluting stents in acute coronary syndroms. Preliminary implantation data and follow up of 40 patients

Joël Sainsous, Jérôme Brunet, Gilles Bayet, François Xavier Hager et autres

0182: Bioresorbable everolimus eluting stents in coronary arteries. Preliminary implantation data and follow up of 65 patients

Joël Sainsous, Gilles Bayet, Jérôme Brunet, Xavier Hager Francois et autres

Very Late Mesenteric Bare Metal Stent Thrombosis in the Setting of Cessation of Antiplatelet Agents

Omar Aït Mokhtar, Gilles Bayet, Saida Benamara, Jérôme Brunet et autres

fr (code pays fourni par la source)

6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin

Martine Gilard, Paul Barragan, Arif A.L. Noryani, Hussam A. Noor et autres

fr, ae, bh, hu (code pays fourni par la source)

Percutaneous Management of Lower Limb Ischemia After the Use of Vascular Closure Devices

S. Rekik, Jérôme Brunet, Gilles Bayet, François Xavier Hager et autres

fr (code pays fourni par la source)